Skip to content

R2P MISAGO SXR06100RRecalls & reported problems

Terumo Corporation · MISAGO RX Self-expanding Peripheral Stent · Class 3 · Implant

All models of R2P MISAGO (13)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04987350727541), received between Jun 28, 2022 and Nov 30, 2023 — classified as 3 injuries.

The most frequently reported specific device problem is “Material Deformation” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Deformation3

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 30, 2023Material Deformation; Material Deformation

    THE USER FACILITY REPORTED THAT A 6X100 MISAGO WAS DEPLOYED IN DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) AREA WHERE SOME PLAQUE DISSECTION WAS PRESENT. UPON DEPLOYMENT THE PROXIMAL END OF THE STENT APPEARED TO BE CRIMPED. THIS MALFORMATION OF DEPLOYMENT WAS NOT FLOW LIMITING, HOWEVER IT WAS A CONCERN FOR THE DOCTOR AFTER PLACEMENT. HE FURTHER INVESTIGATED AND SHOWED UNDER INTRAVASCULAR ULTRASOUND (IVUS) THAT THE FLUOROSCOPY IMAGE WAS CONFIRMED, AND THE TOP OF THE STENT WAS CRIMPED. THE DOCTOR WAS NOT SATISFIED WITH THE STENT AND REALIGNED THE MISAGO WITH A 6X40 ZILVER PTX STENT. THE ARTERY OF THE LOWER EXTREMITY WAS NOT PREVIOUSLY TREATED. RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WAS DISEASED LIMB. SITE OF THE PUNCTURE WAS THE FEMORAL ARTERY CONTRALATERAL VIA ANTEGRADE APPROACH. THE LESION LENGTH 100, WITH A 5MM VESSEL DIAMETER. THE PATIENT WAS STABLE, AND THE PROCEDURE OUTCOME WAS SUCCESSFUL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18239352 ↗
  • InjuryOct 25, 2022Material Deformation; Material Deformation

    THE USER FACILITY REPORTED THAT THE PATIENT NEEDED A RIGHT DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) TO MILD POPLITEAL INTERVENTION. AN ATHERECTOMY WAS DONE WITH A DRUG COATED BALLOON (DCB) TO MID POP TO DISTAL RIGHT SFA, AND STENT FROM MID TO DISTAL SFA. THE ACCESS WAS A CUT DOWN TO THE RIGHT PROXIMAL SFA WITH A SHORT 7 FRENCH SHEATH ANTEGRADE POSITIONED. THE VESSEL WAS 6MM IN DIAMETER AND 150MM IN LENGTH WAS NEEDED. WHEN THE STENT WAS DEPLOYED, THE STENT DID NOT ELONGATE. AFTER DEPLOYMENT, IT SHORTENED. THE STENT LENGTH WAS NOT ENOUGH, AND ANOTHER MISAGO STENT WAS PLACED PROXIMALLY. HOWEVER, IT WAS FORESHORTENED ALSO. THE STENT LENGTH WAS 100MM. THE DOCTOR USED A THIRD STENT TO COVER THE LENGTH TO THE MID SFA. THE STENT WAS A ZILVER BALLOON EXPANDING STENT. THE PATIENT'S VESSEL WAS FULLY OPPOSED, AND FLOW WAS NOT LIMITED. PRIOR TO THE INTERVENTION THE VESSEL WAS A CHRONIC TOTAL OCCLUSION (CTO). THE CASE WAS SUCCESSFUL. THE PATIENT WAS IN STABLE CONDITION. THE PROCEDURE WAS A SUCCESSFUL INTERVENTION OF RIGHT SFA. THE ARTERY OF THE LOWER EXTREMITY WAS NOT PREVIOUSLY TREATED. THE LESION TREATMENT HISTORY WAS DE NOVO. THE RIGHT LIMB WAS DISEASED. THE CALCIFICATION WAS MODERATE. TORTUOU

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15668463 ↗
  • InjuryJun 28, 2022Material Deformation; Material Deformation

    THE USER FACILITY REPORTED THAT A 6X100 MISAGO WAS DEPLOYED IN DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) AREA WHERE SOME PLAQUE DISSECTION WAS PRESENT. UPON DEPLOYMENT THE PROXIMAL END OF THE STENT APPEARED TO BE CRIMPED. THIS MALFORMATION OF DEPLOYMENT WAS NOT FLOW LIMITING, HOWEVER IT WAS A CONCERN FOR THE DOCTOR AFTER PLACEMENT. HE FURTHER INVESTIGATED AND SHOWED UNDER INTRAVASCULAR ULTRASOUND (IVUS) THAT THE FLUOROSCOPY IMAGE WAS CONFIRMED, AND THE TOP OF THE STENT WAS CRIMPED. THE DOCTOR WAS NOT SATISFIED WITH THE STENT AND REALIGNED THE MISAGO WITH A 6X40 ZILVER PTX STENT. THE ARTERY OF THE LOWER EXTREMITY WAS NOT PREVIOUSLY TREATED. RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WAS DISEASED LIMB. SITE OF THE PUNCTURE WAS THE FEMORAL ARTERY CONTRALATERAL VIA ANTEGRADE APPROACH. THE LESION LENGTH 100, WITH A 5MM VESSEL DIAMETER. THE PATIENT WAS STABLE, AND THE PROCEDURE OUTCOME WAS SUCCESSFUL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14849203 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page